Back to Browse Journals » Clinical and Experimental Gastroenterology » Volume 1

Oropharyngeal Crohn’s disease

Authors Rachid Mohamed, Robert Schultz, Richard N Fedorak

Published 4 December 2008 Volume 2008:1 Pages 15—18

DOI http://dx.doi.org/10.2147/CEG.S3755

Review by Single-blind

Peer reviewer comments 3

Rachid Mohamed, Robert Schultz, Richard N Fedorak

Division of Gastroenterology, University of Alberta, Edmonton, Alberta

Abstract: Crohn’s disease is a chronic inflammatory disease that can affect any part of the gastrointestinal tract. Classically the disease has a predilection for the distal small bowel and colon and presents with dominant symptoms of abdominal pain and diarrhea. This case report describes a 38-year-old woman with Crohn’s disease who presented with odynophagia. Direct visualization of the oropharynx revealed a large serpiginous Crohn’s disease ulcer. A precipitous drop in hemoglobin prompted a series of gastroenterologic investigations that confirmed both ileal and oropharyngeal Crohn’s disease. This manuscript describes the presentation of oropharyngeal Crohn’s and reviews previous reports and management options.

Keywords: Crohn’s disease, odynophagia, immunomodulatory therapy, oropharyngeal Crohn’s disease, aphthous ulcer, gastroscopy

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Retrospective analysis of KRAS status in metastatic colorectal cancer patients: a single-center feasibility study

Montomoli J, Hamilton-Dutoit SJ, Frøslev T, Taylor A, Erichsen R

Clinical and Experimental Gastroenterology 2012, 5:167-171

Published Date: 18 September 2012

Corrigendum

Kukulka M, Eisenberg C, Nudurupati S

Clinical and Experimental Gastroenterology 2011, 4:255-256

Published Date: 14 October 2011

Role of prucalopride, a serotonin (5-HT4) receptor agonist, for the treatment of chronic constipation

Banny S Wong, Noriaki Manabe, Michael Camilleri

Clinical and Experimental Gastroenterology 2010, 3:49-56

Published Date: 24 May 2010

Amantadine reduces glucagon and enhances insulin secretion throughout the oral glucose tolerance test: central plus peripheral nervous system mechanisms

Fuad Lechin, Bertha van der Dijs, Betty Pardey-Maldonado, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:203-213

Published Date: 2 December 2009

Do we at all need surgery to treat thrombosed external hemorrhoids? Results of a prospective cohort study

Ole Gebbensleben, York Hilger, Henning Rohde

Clinical and Experimental Gastroenterology 2009, 2:69-74

Published Date: 30 June 2009

Methylnaltrexone in the treatment of opioid-induced constipation

Beverley Greenwood-Van Meerveld, Kelly M Standifer

Clinical and Experimental Gastroenterology 2008, 1:49-58

Published Date: 14 December 2008

Organic anion transporting polypeptide 1B3 (OATP1B3) is overexpressed in colorectal tumors and is a predictor of clinical outcome

Albert Craig Lockhart, Elizabeth Harris, Bonnie J LaFleur, Nipun B Merchant, Mary Kay Washington, et al

Clinical and Experimental Gastroenterology 2008, 1:1-7

Published Date: 2 November 2008